NCT03908970View on ClinicalTrials.gov

Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

December 28, 2019

Study Completion Date

December 28, 2019

Conditions
Atopic Dermatitis
Interventions
DRUG

1% OPA-15406

Twice daily

DRUG

Placebos

Twice daily

Trial Locations (1)

Unknown

Kitago Hifuka Clinic, Sapporo

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY